BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2763314)

  • 41. Heavy metals and enzyme induction.
    Stoytchev T; Kadiiska M
    Acta Physiol Pharmacol Bulg; 1983; 9(1):29-34. PubMed ID: 6624490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
    Pfeifer A; Neumann HG
    Drug Metab Dispos; 1988; 16(2):276-84. PubMed ID: 2898347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative immunosuppression of various glycol ethers orally administered to Fischer 344 rats.
    Smialowicz RJ; Williams WC; Riddle MM; Andrews DL; Luebke RW; Copeland CB
    Fundam Appl Toxicol; 1992 May; 18(4):621-7. PubMed ID: 1526376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of mRNA coding for phenobarbital-inducible form of microsomal cytochrome P-450 in rat liver by administration of 1,1-Di(p-chlorophenyl)-2,2-dichloroethylene and phenobarbital.
    Morohashi K; Yoshioka H; Sogawa K; Fujii-Kuriyama Y; Omura T
    J Biochem; 1984 Apr; 95(4):949-57. PubMed ID: 6547716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the in vivo metabolism of hydralazine in the rat.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):184-9. PubMed ID: 6135573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of nifedipine on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone.
    Koleva M; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):122-8. PubMed ID: 1819909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of bis(2-chloroethyl)ether and bis(2-chloroisopropyl)ether in the rat.
    Lingg RD; Kaylor WH; Pyle SM; Domino MM; Smith CC; Wolfe GF
    Arch Environ Contam Toxicol; 1982; 11(2):173-83. PubMed ID: 6807217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of phenobarbital pretreatment on the plasma and urinary levels of (-)-alpha-acetylmethadol and its metabolites.
    Kuttab SH; Nowshad F; Shargel L
    J Pharm Sci; 1985 Mar; 74(3):331-4. PubMed ID: 4009444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of pretreatment with cytochrome P-450 inducers, especially phenobarbital on triphenyltin metabolism and toxicity in hamsters.
    Ohhira S; Matsui H; Watanabe K
    Toxicology; 1999 Oct; 137(3):151-9. PubMed ID: 10522495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Methoxyethanol metabolism, embryonic distribution, and macromolecular adduct formation in the rat: the effect of radiofrequency radiation-induced hyperthermia.
    Cheever KL; Swearengin TF; Edwards RM; Nelson BK; Werren DW; Conover DL; DeBord DG
    Toxicol Lett; 2001 May; 122(1):53-67. PubMed ID: 11397557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel mechanism for the enhancement of acetaminophen hepatotoxicity by phenobarbital.
    Douidar SM; Ahmed AE
    J Pharmacol Exp Ther; 1987 Feb; 240(2):578-83. PubMed ID: 3806412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3,5-Dichloroaniline toxicity in Fischer 344 rats pretreated with inhibitors and inducers of cytochrome P450.
    Valentovic MA; Lo HH; Brown PI; Rankin GO
    Toxicol Lett; 1995 Aug; 78(3):207-14. PubMed ID: 7624891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of methyl tertiary-butyl ether by rat hepatic microsomes.
    Brady JF; Xiao F; Ning SM; Yang CS
    Arch Toxicol; 1990; 64(2):157-60. PubMed ID: 2350236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of nifedipine, verapamil and diltiazem on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone.
    Koleva MR; Stoychev TS
    Gen Pharmacol; 1995 Jan; 26(1):225-8. PubMed ID: 7713363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.
    Turesky RJ; Markovic J; Bracco-Hammer I; Fay LB
    Carcinogenesis; 1991 Oct; 12(10):1847-55. PubMed ID: 1934266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative potency of four ethylene glycol ethers for induction of paw malformations in the CD-1 mouse.
    Hardin BD; Eisenmann CJ
    Teratology; 1987 Jun; 35(3):321-8. PubMed ID: 3629512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex.
    Thakore KN; Gargas ML; Andersen ME; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):514-28. PubMed ID: 1712992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
    Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.